2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
JBS N.V. submitted a non-binding proposal to Pilgrim's Pride's board to acquire all PPC shares it does not already own, in exchange for 2.086 JBS Class A shares per PPC share. JBS owns about 82% of PPC, and the filing says there is no guarantee a binding agreement will be reached. For PPC minority shareholders, the proposal would replace their PPC shares with JBS shares and end PPC's public listing if completed.
Exchange ratio of 2.086 JBS Class A shares per PPC share, based on August 18, 2026 closing prices of $13.66 for JBS and $28.49 for PPC
JBS currently owns approximately 82% of PPC common stock
Proposal requires approval by a special committee of independent directors and a majority of votes cast by unaffiliated PPC shares; it is not binding
If completed, PPC shares would stop trading on Nasdaq and be deregistered
Jack Henry reported fourth-quarter and full-year fiscal 2026 results for the period ended June 30, 2026. Full-year GAAP revenue and diluted EPS rose, but fourth-quarter GAAP operating income and EPS declined from the prior year quarter. The company also issued fiscal 2027 GAAP EPS guidance of $7.33 to $7.38, which assumes no acquisitions or dispositions, and it spent $448 million on stock repurchases during the fiscal year.
Fourth-quarter GAAP revenue rose 4.7% to $644 million, while GAAP operating income fell 12.2% to $137 million and GAAP EPS fell to $1.57 from $1.75.
Full-year GAAP revenue rose 7.1% to $2.54 billion, and GAAP EPS rose 11.9% to $6.98 from $6.24.
Fiscal 2027 GAAP revenue guidance is $2,684 million to $2,709 million, and GAAP EPS guidance is $7.33 to $7.38.
Stock repurchases were $448 million for the fiscal year at an average price of $152 per share, including $164 million in the fourth quarter at $140 per share.
Beyond Air reported revenue of $1.8 million for the quarter ended June 30, 2026, unchanged from the prior-year quarter, while its net loss attributable to common stockholders widened to $7.9 million from $7.7 million. The company reaffirmed its calendar 2026 revenue guidance of $8 million and its 2027 guidance of $16-$18 million, and disclosed a financing of up to $30.1 million, including $10.2 million in upfront gross proceeds, which it said will fund international expansion and a U.S. launch pending FDA approval.
Revenue was $1.8 million in both the quarter ended June 30, 2026 and the same quarter of 2025; gross margin rose to 13% from 9%.
Net loss attributable to common stockholders was $7.9 million, or $11.00 per share, versus $7.7 million, or $30.67 per share, a year earlier; per-share figures reflect a one-for-twenty stock split in July 2026.
Cash, cash equivalents, restricted cash and marketable securities totaled $15.2 million at June 30, 2026, before the financing of up to $30.1 million announced after quarter-end.
The company said it regained compliance with Nasdaq's minimum bid price requirement and that the FDA review of the second-generation LungFit PH PMA supplement is pending, with approval expected in the second half of calendar 2026.
Agenus and its subsidiary Agenus West amended a loan from Ocean 1181 LLC, with the outstanding principal unchanged at $24,750,000 and maturity extended to November 30, 2029. The loan carries a 13.0% annual interest rate, and interest and a $247,500 extension fee will be paid partly in newly issued common stock, which adds potential dilution for shareholders.
Outstanding principal remains $24,750,000; maturity extended to November 30, 2029
Interest rate of 13.0% per annum through maturity; monthly interest payable one-half in cash and one-half in common stock
Extension fee of $247,500, payable one-half in cash and one-half in common stock
Agreement signed August 12, 2026; shares to be issued to the lender in exempt private transactions
Liminatus Pharma said it will carry out a 1-for-50 reverse stock split of its common stock, effective August 20, 2026, so its shares can meet Nasdaq's $1.00 minimum bid price. The company remains listed under a Nasdaq Panel exception, but it must show a $1.00 closing bid for at least ten consecutive trading days by September 3, 2026, and the company says it cannot assure it will do so.
Reverse split ratio of 1-for-50, with split-adjusted trading under LIMN on The Nasdaq Capital Market expected at the market open on August 21, 2026
New CUSIP number 53271X 207; fractional shares will be rounded up to the nearest whole share, with no cash paid for fractions
Based on July 2, 2026 figures, outstanding shares would fall from 67,160,362 to approximately 1,343,208
Nasdaq Panel extended the deadline to demonstrate compliance with Listing Rule 5550(a)(2) to September 3, 2026
Mercury Systems reported fourth-quarter and fiscal 2026 results for the period ended July 3, 2026. Revenue grew, and bookings and backlog hit company records, but fourth-quarter GAAP net income fell to $1 million from $16 million a year earlier, and management said it is increasing its organic growth outlook without giving new figures.
Q4 fiscal 2026 revenue was $290 million, up from $273 million; bookings were $660 million, up 93.1%
Q4 GAAP diluted EPS was $0.01 versus $0.27 a year earlier; adjusted EBITDA was $49 million versus $51 million
Full-year revenue rose to $984 million from $912 million; GAAP net loss narrowed to $30 million ($0.50 per share) from $38 million
Backlog exceeded $1.9 billion, up 38.4% year over year; management said it is increasing its outlook for organic growth
On August 17, 2026, Cypherpunk agreed to buy mining equipment and hosting agreements from Moria Mining, LLC for $33,333,333, paid by issuing a pre-funded warrant to Winklevoss Treasury Investments, LLC (WTI) for 43,290,042 common shares. The deal adds Zcash mining capacity but also commits a large block of new shares to an affiliate of the seller, which shareholders should weigh against the expanded operations.
Purchase price is $33,333,333 for Z15 Pro mining machines with about 4.2 GSol/s of hashpower and related hosting agreements.
Payment is a pre-funded warrant for 43,290,042 shares at an exercise price of $0.001 per share; the company says this reflects a $0.77 per share common stock price.
Warrant exercise is capped at 19.99% beneficial ownership; the company will seek stockholder approval at its next annual meeting for issuance above 5,377,442 shares.
WTI, an affiliate of the seller, owns 19.9% of the company's stock and has appointed William McEvoy and Khing Oei to the board.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.